Brexit costs and red tape are denying British cancer patients life-saving drugs and trials of revolutionary treatments, a damning new report has warned.
Soaring numbers are being diagnosed with cancer as the population grows alongside improvements in diagnosis and public awareness, heightening the importance of global cooperation on new treatments.